Cargando…

Sequential gene profiling of basal cell carcinomas treated with imiquimod in a placebo-controlled study defines the requirements for tissue rejection

BACKGROUND: Imiquimod is a Toll-like receptor-7 agonist capable of inducing complete clearance of basal cell carcinoma (BCC) and other cutaneous malignancies. We hypothesized that the characterization of the early transcriptional events induced by imiquimod may provide insights about immunological e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Panelli, Monica C, Stashower, Mitchell E, Slade, Herbert B, Smith, Kina, Norwood, Christopher, Abati, Andrea, Fetsch, Patricia, Filie, Armando, Walters, Shelley-Ann, Astry, Calvin, Aricó, Eleonora, Zhao, Yingdong, Selleri, Silvia, Wang, Ena, Marincola, Francesco M
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1839129/ https://www.ncbi.nlm.nih.gov/pubmed/17222352 http://dx.doi.org/10.1186/gb-2007-8-1-r8

Ejemplares similares

Gene expression profiling of cutaneous wound healing
por: Deonarine, Kavita, et al.
Publicado: (2007)

Delayed polarization of mononuclear phagocyte transcriptional program by type I interferon isoforms
por: Stroncek, David F, et al.
Publicado: (2005)

Forecasting the cytokine storm following systemic interleukin (IL)-2 administration
por: Panelli, Monica C, et al.
Publicado: (2004)

A strategy for detection of known and unknown SNP using a minimum number of oligonucleotides applicable in the clinical settings
por: Wang, Ena, et al.
Publicado: (2003)

Selection and validation of endogenous reference genes using a high throughput approach
por: Jin, Ping, et al.
Publicado: (2004)

Polarized monocyte response to cytokine stimulation
por: Nagorsen, Dirk, et al.
Publicado: (2005)

Concomitant detection of IFNα signature and activated monocyte/dendritic cell precursors in the peripheral blood of IFNα-treated subjects at early times after repeated local cytokine treatments
por: Aricò, Eleonora, et al.
Publicado: (2011)

Transcriptomic profiles conducive to immune-mediated tumor rejection in human breast cancer skin metastases treated with Imiquimod
por: Rozenblit, Mariya, et al.
Publicado: (2019)

Management of superficial basal cell carcinoma: focus on imiquimod
por: Raasch, Beverly
Publicado: (2009)

Optimized dithranol-imiquimod-based transcutaneous immunization enables tumor rejection
por: Hartmann, Ann-Kathrin, et al.
Publicado: (2023)

Dermatoscopy-guided therapy of pigmented basal cell carcinoma with imiquimod
por: Husein-ElAhmed, Husein, et al.
Publicado: (2016)

Molecular signatures induced by interleukin-2 on peripheral blood mononuclear cells and T cell subsets
por: Jin, Ping, et al.
Publicado: (2006)

A Multi-Factorial Genetic Model for Prognostic Assessment of High Risk Melanoma Patients Receiving Adjuvant Interferon
por: Wang, Ena, et al.
Publicado: (2012)

PIGMENTED BASAL CELL CARCINOMA SUCCESSFULLY TREATED WITH 5% IMIQUIMOD CREAM
por: Mehta, Vandana, et al.
Publicado: (2008)

IRF-1 responsiveness to immune cytokines predicts different cancer phenotypes
por: Murtas, Daniela, et al.
Publicado: (2013)

Gene expression profiling in acute allograft rejection: challenging the immunologic constant of rejection hypothesis
por: Spivey, Tara L, et al.
Publicado: (2011)

Topical 5% Imiquimod Sequential to Surgery for HPV-Related Squamous Cell Carcinoma of the Lip
por: Pentangelo, Giovanni, et al.
Publicado: (2021)

The application of Levulan(®)-based photodynamic therapy with imiquimod in the treatment of recurrent basal cell carcinoma
por: Osiecka, Beata Joanna, et al.
Publicado: (2012)

Facial Basal Cell Carcinoma Treated with Topical 5% Imiquimod Cream with Dermoscopic Evaluation
por: Singal, Archana, et al.
Publicado: (2016)

GM-CSF/IL-3/IL-5 receptor common β chain (CD131) expression as a biomarker of antigen-stimulated CD8(+ )T cells
por: Selleri, Silvia, et al.
Publicado: (2008)

An old friend with new skills: Imiquimod as novel inhibitor of Hedgehog signaling in basal cell carcinoma
por: Gruber, Wolfgang, et al.
Publicado: (2014)

Imiquimod 5% cream for the treatment of large nodular basal cell carcinoma at the medial canthal area
por: Karabulut, Gamze Ozturk, et al.
Publicado: (2017)

Self-motion perception and sequential decision-making: where are we heading?
por: Jerjian, Steven J., et al.
Publicado: (2023)

Striatal Neuropeptides Enhance Selection and Rejection of Sequential Actions
por: Buxton, David, et al.
Publicado: (2017)

Imiquimod cream efficacy in the treatment of periocular nodular basal cell carcinoma: a non-randomized trial
por: Macedo, Erick Marcet Santiago de, et al.
Publicado: (2015)

Imiquimod (Aldara cream).
por: Buck, H W
Publicado: (1998)

The immunologic constant of rejection classification refines the prognostic value of conventional prognostic signatures in breast cancer
por: Bertucci, François, et al.
Publicado: (2018)

Successful Treatment of Giant Basal Cell Carcinoma with Topical Imiquimod 5% Cream with Long Term Follow-up
por: Chun-Guang, M, et al.
Publicado: (2014)

Reflectance Confocal Microscopy Follow-up of Multifocal Superficial Basal Cell Carcinomas Treated With Imiquimod 5% Cream
por: Zou, Yunmin, et al.
Publicado: (2022)

Gene-expression profiling of the response of peripheral blood mononuclear cells and melanoma metastases to systemic IL-2 administration
por: Panelli, Monica C, et al.
Publicado: (2002)

IRF-1 responsiveness to IFN-γ predicts different cancer immune phenotypes
por: Murtas, D, et al.
Publicado: (2013)

Imiquimod 5% as Adjuvant Therapy for Incompletely Excised Infiltrative Nodular Basal Cell Carcinoma and Dermoscopy to Monitor Treatment Response
por: Roldán-Marín, Rodrigo, et al.
Publicado: (2015)

Pilot clinical trials testing the safety and effects on the metastatic melanoma microenvironment of intratumoral interferon-gamma or imiquimod, plus a multipeptide melanoma vaccine
por: Mauldin, Ileana S, et al.
Publicado: (2015)

S75. KEYNOTE LECTURE: Basic concept for the understanding of cancer mediated immune rejection
por: Marincola, F, et al.
Publicado: (2014)

Immune-mediated changes in actinic keratosis following topical treatment with imiquimod 5% cream
por: Torres, Abel, et al.
Publicado: (2007)

Lack of efficacy of imiquimod in patients with basal cell carcinoma previously treated with rituximab for B cell lymphoma: two case reports
por: Campione, Elena, et al.
Publicado: (2016)

Superficial Basal Cell Carcinoma on the Back Region Treated with a Combination of Cryotherapy and 5% Imiquimod Cream: A Case Report
por: Sutedja, Eva Krishna, et al.
Publicado: (2023)

Topical Imiquimod Treatment of Lentigo Maligna
por: Ventura, F., et al.
Publicado: (2009)

Bowen's Disease Treated with Imiquimod and Cryotherapy
por: Patel, Krina B
Publicado: (2012)

Melanoma Arising after Imiquimod Use
por: Paul, Sharad P.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_t57260t2vf2mr1q7hfdgr6d6v0